期刊文献+

左西孟旦治疗急性失代偿性心力衰竭近期疗效评价 被引量:4

The Short-term Effect of Leosimendan in the Treatment of Acute Decompensated Heart Failure
下载PDF
导出
摘要 目的:探讨左西孟旦治疗急性失代偿性心力衰竭(ADHF)的疗效性和安全性。方法:85例ADHF患者随机分为研究组和对照组。对照组给予基础治疗,研究组在此基础上加用左西孟旦注射液治疗24 h。比较两组治疗后7 d的左室射血分数(LVEF)、每搏量(SV)、左室舒张末内径(LVEDD)、左室收缩末内径(LVESD)、B型利钠肽(BNP)、24 h尿量和NYHA心功能变化情况,评价两组疗效和药品不良反应。结果:两组治疗后LVEF、BNP和24h尿量均较前有明显改变(P<0.05)。两组治疗后LVEF、BNP和24 h尿量比较,差异均有统计学意义(P<0.05),但SV、LVESD和LVEDD比较差异无统计学意义(P>0.05)。两组治疗前后NYHA心功能分级比较,差异均有统计学意义(P<0.05),两组治疗后比较,差异也有统计学意义(P<0.05)。研究组和对照组的总有效率分别为72.09%和54.77%,但差异无统计学意义(P>0.05)。两组不良反应发生率分别为30.23%和11.90%,差异有统计学意义(P<0.05)。结论:左西孟旦治疗ADHF能改善心脏功能,但应注意低血压和心律失常的发生。 Objective :To evaluate the efficacy and safety of leosimendan in the treatment of acute decompensated heart failure. Methods:85 cases with acute decompensated heart failurewere randomly divided into study group and control group. The control group were treated with conventional medicines, and the study group were given leosimendan additional- ly for 24h. The changes of LVEF, SV, LEEDD, LVESD, BNP, 24 h urine volume and NYHA classification were evalua- ted, as well as efficacy and safety. Results: The values of LVEF, BNP, 24 h urine volume and NYHA classification changed more obviously than those before treatment ( P 〈 0.05 ), but the SV and LVEDD produced almost no change ( P 〉 0.05 ). There were still significantly differences in LVEF, BNP, 24 h urine volume and NYHA Classification compared be- tween groups after treatment ( P 〈 0.05 ), but there were no significantly differences in SV, LVESD and LVEDD compared between two groups after treatment( P 〉0.05 ). The total effective rate was 72.09% in study group, higher than 54.77% in control group. But there was no statistical difference between the two groups ( P 〉 0.05 ). The rate of adverse reaction was 30.23% ( 13/43), higher than 11.90% (5/42) in control group (P 〈0.05). Conclusion: Leosimendan in the treat- ment of acute decompensated heart failure can significantly improve heart function, but we should pay more attention to the occurrence of low blood pressure and cardiac arrhythmias.
出处 《药物流行病学杂志》 CAS 2014年第10期587-589,592,共4页 Chinese Journal of Pharmacoepidemiology
关键词 左西孟旦 急性失代偿性心力衰竭 心功能 低血压 Leosimendan Acute decompensated heart failure Heart function Low blood pressure
  • 相关文献

参考文献8

二级参考文献76

  • 1心肌病诊断与治疗建议[J].中华心血管病杂志,2007,35(1):5-16. 被引量:554
  • 2Nieminen MS,Bohm M,Cowie MR,et al.Executive summary of the guidelines on the diagnosis and treatment of acute heart failure:the Task Force on Acute Heart Failure of the European Society of Cardiology.Eur Heart J,2005,26:384-416. 被引量:1
  • 3Follath F,Cleland JG,Just H,et al.Efficacy and safety of intravenous levosimendan compared with dubutamine in severe lowoutput heart failure (the LIDO study):a randomised donble-blind trial.Lancet,2002,360:196-202. 被引量:1
  • 4Moiseyev VS,Poder P,Andrejevs N,et al.Safety and efficacy of a novel calcium sensitizer,levosimendan,in patients with left ventricular failure due to an acute myocardial infarction.A randomized,placebo-controlled,double-blind study (RUSSIAN).Eur Heart J,2002,23:1422-1432. 被引量:1
  • 5Cleland JG,Ghosh J,Freemantle N,et al.Clinical trials update and cumulative meta-analyses from the American College of Cardiology:WATCH,SCD-HeFT,DINAMIT,CASINO,INSPIRE,STRATUS-US,RlO-Lipids and cardiac resynchronisation therapy in heart failure.Eur J Heart Fail,2004,6:501-508. 被引量:1
  • 6McMurray JJ,Pfeffer MA.Heart failure.Lancet,2005,365:1877-1889. 被引量:1
  • 7Lloyd-Jones DM,Larsen MG,Leip EP,et al.Lifetime risk for developing congestive heart failure:the Framingham Heart Study.Circulation,2002,106:3068-3072. 被引量:1
  • 8Sharma M,Tserlink JR.A rational approach for the treatment of acute heart failure:current strategies and future options.Curr Opin Cardiol,2004,19:254-263. 被引量:1
  • 9Dec GW.Acute decompensated heart failure:the shrinking role of inotropic therapy.J Am Coil Cardiol,2005,46:65-67. 被引量:1
  • 10Nieminen MS,Akkila J,Hasenfuss G,et al.Hemodynamic and neurohumoral effects of continuous infusion of levesimendan in patients with congestive heart failure.J Am Coll Cardiol,2000,36:1903-1912. 被引量:1

共引文献137

同被引文献23

  • 1Chen J, Normand ST, Wang Y, et al. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries[ J ]. JAMA ,2011, 306 : 1669-1678. 被引量:1
  • 2Packer M, Carver JR, Rodeheffer RJ ,et al. Effect of oral milfinone on mortality in severe chronic heart failure [ J]. N Engl J Med, 1991, 325 : 1468-1475. 被引量:1
  • 3O' Connor CM, Gattis WA, Uretsky BF ,et al. Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure:insights from the ~olan International Randomized Survival Trial (FIRST) [ J]. Am Heart J, 1999,138:78-86. 被引量:1
  • 4Metra M, Ponikowski P, Dickstein K, et al. Advanced chronic heart failure : a position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology[ J. ] Eur J Heart Fail ,2007,9: 684-694. 被引量:1
  • 5Earl GL, Fitzpatrick JT. Levosimendan: a novel inotmpic agent for treatment of acute decompensated heart failure[ J]. Ann Pharmacother, 2005,39 : 1888 -1896. 被引量:1
  • 6Leier CV, Binkley PF. Parenteral inotropic support for advanced congestive heart failure[ J]. Prog Cardiovasc Dis,1998,41 : 207-224. 被引量:1
  • 7Kivikko M, Lehtonen L, Colucci WS. Sustained hemodynamic effects of intravenous levosimendan[ J]. Circulation, 2003,107:81-86. 被引量:1
  • 8De Luca L, Colucci WS, Nieminen MS,et al. Evidence-based use of levosimendan in different clinical settings[ J]. Eur Heart J,2006,27 : 1908-1920. 被引量:1
  • 9Mavrogeni S, Giamouzis G, Papadopoulou E, et al. A 6-month followup of repeated levosim-endan administration effects on systolic function, specific activity questionnaire, and arrhythmia in advanced heart failure[ J]. J Card Fail,2007,13:556-559. 被引量:1
  • 10Parissis JT, Adamopoulos S, Farmakis D,et al. Effects of serial levosimendan infusions on left ventricular performance and plasma biomarkers of myocardial injury and neurohormonal and imune activation in patients with advanced heart failure [ J ]. Heart ,2006,92:1768-1772. 被引量:1

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部